Oxford Biotherapeutics is a clinical-stage biotechnology company focusing on the development of antibody therapeutics for the treatment of cancer. OBT’s OGAP-verify® platform is the world's largest, cancer specific, membrane protein library, directly measuring plasma membrane protein expression in patient tumors. OGAP is used to identify novel, highly tumor specific antigens for novel first-in-class ADC, T-cell Engager (TCE ) and Chimeric Antigen Receptor (CAR-T) targets. Our lead asset, OBT076, is an Antibody Drug Conjugate (ADC) in Phase 1b clinical development. Our clinical and pre-clinical pipeline of novel biologics is balanced between internal programs, focused on ADCs and checkpoint regulators, and externally partnered programs with key innovators in oncology such as Roche, GSK and BMS. OBT is seeking an experienced, creative and motivated associate scientist to contribute to our company's Discovery Biologics Protein Science group. Work independently, and in a matrix, to lead the development of antigen antibodies against novel targets discovered by Oxford Biotherapeutics, headquartered in the UK. The successful candidate will be involved in multiple aspects of the production of recombinant proteins, monoclonal antibodies, multi-specific scaffolds, and novel protein modalities to enable all aspects of Early Discovery and Validation Research.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Education Level
Ph.D. or professional degree